INTEGRATED BIOPHARMA INC financial data

Symbol
INBP on OTC
Location
Hillside, NJ
Fiscal year end
30 June
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 384 % +33.8%
Quick Ratio 209 % +14%
Debt-to-equity 25.76 % -31.8%
Return On Equity 3.32 % +47.4%
Return On Assets 2.64 % +61.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31,059,610 shares +3.2%
Common Stock, Shares, Outstanding 31,059,610 shares +3.1%
Entity Public Float 3,111,877 USD -7.6%
Common Stock, Value, Issued 62,000 USD +3.3%
Weighted Average Number of Shares Outstanding, Basic 31,059,610 shares +3.2%
Weighted Average Number of Shares Outstanding, Diluted 31,421,338 shares +2.5%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) 1,693,000 USD +1.1%
Nonoperating Income (Expense) 39,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1,754,000 USD +1.1%
Income Tax Expense (Benefit) 1,082,000 USD +1.8%
Net Income (Loss) Attributable to Parent 672,000 USD +56.3%
Earnings Per Share, Basic 0 USD/shares +100%
Earnings Per Share, Diluted 0 USD/shares +100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4,732,000 USD +1.1%
Accounts Receivable, after Allowance for Credit Loss, Current 3,983,000 USD -9.2%
Inventory, Net 10,469,000 USD -6.7%
Other Assets, Current 440,000 USD +1.9%
Assets, Current 19,624,000 USD +7.2%
Deferred Income Tax Assets, Net 3,269,000 USD -25.8%
Property, Plant and Equipment, Net 1,819,000 USD -1.8%
Operating Lease, Right-of-Use Asset 612,000 USD -60.7%
Assets 25,540,000 USD -2.5%
Accounts Payable, Current 2,800,000 USD +1.3%
Liabilities, Current 4,764,000 USD -21%
Operating Lease, Liability, Noncurrent 183,000 USD -69.7%
Liabilities 5,051,000 USD -23.8%
Retained Earnings (Accumulated Deficit) -31,296,000 USD +2.1%
Stockholders' Equity Attributable to Parent 20,489,000 USD +4.8%
Liabilities and Equity 25,540,000 USD -2.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1,301,000 USD +98%
Net Cash Provided by (Used in) Financing Activities -11,000 USD -57.1%
Net Cash Provided by (Used in) Investing Activities -173,000 USD -2.1%
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 31,094,510 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1,117,000 USD +88%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2,000 USD -83.3%
Deferred Tax Assets, Valuation Allowance 1,776,000 USD +39.7%
Operating Lease, Liability 1,323,000 USD
Depreciation 310,000 USD -1.6%
Payments to Acquire Property, Plant, and Equipment 173,000 USD +2.1%
Lessee, Operating Lease, Liability, to be Paid 1,400,000 USD
Property, Plant and Equipment, Gross 10,086,000 USD +2.2%
Operating Lease, Liability, Current 429,000 USD -55%
Lessee, Operating Lease, Liability, to be Paid, Year Two 169,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One 661,000 USD
Deferred Income Tax Expense (Benefit) 68,000 USD -65.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 77,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 64,000 USD
Deferred Tax Assets, Operating Loss Carryforwards 4,367,000 USD -13.2%
Deferred Federal Income Tax Expense (Benefit) 1,247,000 USD +3%
Operating Lease, Payments 254,000 USD -4.5%
Additional Paid in Capital 51,822,000 USD +0.51%
Depreciation, Depletion and Amortization 77,000 USD -9.4%
Deferred State and Local Income Tax Expense (Benefit) -183,000 USD -4.7%
Interest Expense 52,000 USD 0%